Trader consensus heavily favors no new pandemic in 2026, with 88.5% implied odds on "No," driven by the absence of any novel pathogen exhibiting sustained human-to-human transmission or global spread potential, per WHO and CDC surveillance data. Current conditions show H5N1 avian influenza confined to sporadic animal cases and mild human infections in the U.S., without efficient airborne spread, while mpox clade Ib remains regionally limited in Africa despite ongoing monitoring. Enhanced global systems—bolstered by post-COVID wastewater tracking and mRNA vaccine platforms—have contained threats effectively, reducing baseline annual pandemic risk to under 5% based on historical precedents like 2009 H1N1. Recent developments, including stabilized COVID variants and no escalations in Ebola or Marburg, reinforce this stability, though experts caution zoonotic spillover remains an unpredictable wildcard.